Despite being only recently coined in 2023, CKM syndrome exposes the widespread and interconnected nature of heart, kidney, and metabolic diseases, prompting a shift towards early detection and integrated treatment strategies.
Susan Gilchrist, a preventive cardiologist and epidemiologist at the University of North Carolina, says many patients arriving at a dedicated cardiovascular-kidney-metabolic clinic have little idea why they are being treated for a condition they have never heard of. That is hardly surprising: the American Heart Association only coined the term CKM syndrome in 2023, even though it is estimated to affect the vast majority of US adults.
The AHA describes CKM syndrome as a framework that links heart disease, kidney disease, diabetes and obesity, rather than a single illness. The National Kidney Foundation says the same lens also helps explain how fatty liver disease can fit into the picture. The point, specialists say, is that the heart, kidneys and metabolic system do not fail in isolation; one problem often accelerates the others.
Muthiah Vaduganathan of Brigham and Women’s Hospital says the condition reflects the overlap of common risk factors such as excess weight, high blood pressure, raised blood sugar, abnormal cholesterol and declining kidney function. The AHA breaks CKM into four stages, beginning with people who have no obvious risk factors and ending with those who already have established cardiovascular disease and kidney failure. Even before symptoms appear, dangerous metabolic fat, often signalled by a large waist and high glucose, can drive inflammation, insulin resistance and higher blood pressure.
Joshua Joseph of Ohio State University Wexner Medical Center says the damage can become self-reinforcing: high blood sugar and high blood pressure injure the small vessels that feed the kidneys, the kidneys struggle to clear fluid, blood volume rises and the heart is forced to work harder. That spiral can eventually end in heart failure or kidney failure. The good news, clinicians say, is that CKM can often be tackled with the same playbook, starting with Mediterranean-style eating, regular exercise, better sleep, avoiding nicotine and structured weight-loss programmes, then moving to medicines including metformin, statins, ACE inhibitors, GLP-1 drugs and SGLT2 inhibitors. Formal guidance for doctors was only completed in June 2026, reflecting a push to catch risk earlier rather than wait for patients to reach hospital.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
